FindTrial
Sign In

Impact of bariatric surgery on the use of medicines and the quality of life of obese patients

Evaluation of the impact of bariatric surgery on medication use and quality of life in obese patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-3czdjv7
Enrollment
Unknown
Registered
2021-06-04
Start date
2015-03-10
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

The study included 25 people with obesity not yet treated with a surgical procedure according to the following criteria: age between 18 and 60 years, obese with a Body Mass Index (BMI) = 30Kg / m², wh
C18.452.394.750
E02.570.500.062

Sponsors

Universidade Federal do Vale do São Francisco
Lead Sponsor
Universidade Federal do Vale do São Francisco
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Obese volunteers not treated with surgery; obese with a body mass index greater than 30 kilos per square meter; age between 18 and 60 years

Exclusion criteria

Exclusion criteria: Pregnant women; breastfeeding women

Design outcomes

Primary

MeasureTime frame
t is expected to show through the Quality of Life Questionnaire (WHOQOL-bref) an improvement in the quality of life of obese participants after undergoing bariatric surgery. In all domains of quality of life, the results are superior after the surgical procedure. In addition, to show the reduction in the amount of drugs used and the comorbidities after the surgery, with emphasis on systemic arterial hypertension—

Secondary

MeasureTime frame
No secondary outcomes are expected.—

Countries

Brazil

Contacts

Public ContactDeuzilane Nunes
deuzilane.nunes@univasf.edu.br+ 55 - 87 - 999790732

Outcome results

None listed

Source: REBEC (via WHO ICTRP)